US Patent 9217038 MUC1 antibodies
Patent 9217038 was granted and assigned to Glycotope GmbH on December, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+350 characters)
Article
Patent abstract
The present invention pertains to anti-mucin antibodies having improved antigen binding and/or recognition properties as well as a method for improving the antigen binding and/or recognition of an anti-mucin antibody. In particular, the present invention is directed to anti-MUC1 antibodies which are useful in the treatment of cancer.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09217038 MUC1 antibodies US Patent 9217038 MUC1 antibodies
Infobox
Patent Number
09217038
Patent Number
9217038
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09217038 MUC1 antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09217038
Date of patent
December 22, 2015
Patent application number
13387587
Date Filed
July 30, 2010
Patent primary examiner
Find more entities like US Patent 9217038 MUC1 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
